J C Quintero - JoVE Visualize

Showing results (11-20 of 24) with videos related to

Pageof 3

Sort By:

Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987

Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptorS H Socher, M W Riemen, D Martinez, et al.

Journal of Periodontal Research|November 1, 1995

Synthesis of proinflammatory cytokines by human gingival fibroblasts in response to lipopolysaccharides and interleukin-1 betaS Agarwal, C Baran, N P Piesco, et al.

Veterinary Immunology and Immunopathology|December 1, 1989

In vitro induction of swine peripheral blood monocyte proliferation by the fibroblast-derived murine hematopoietic growth factor CSF-1E V Genovesi, R C Knudsen, D J Gerstner, et al.

Revista De Neurologia|November 24, 1999

[Bourneville's tuberous sclerosis associated with double uterus and vagina (didelphic uterus)]C H Castaño-Duque, M Nadal, J C Quintero, et al.

Journal of Virology|September 1, 1991

Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitorsJ H Nunberg, W A Schleif, E J Boots, et al.

Nature|April 6, 1995

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsJ H Condra, W A Schleif, O M Blahy, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitorJ P Vacca, B D Dorsey, W A Schleif, et al.

Journal of Medicinal Chemistry|October 14, 1994

L-735,524: the design of a potent and orally bioavailable HIV protease inhibitorB D Dorsey, R B Levin, S L McDaniel, et al.

Drug Design and Discovery|January 1, 1993

HIV-1 protease inhibitors: synthesis and biological evaluation of glycopeptidemimeticsA K Ghosh, S P McKee, W M Sanders, et al.

Journal of Medicinal Chemistry|May 15, 1992

Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted designW J Thompson, P M Fitzgerald, M K Holloway, et al.

Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:

Pageof 3

Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987

Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptorS H Socher, M W Riemen, D Martinez, et al.

Journal of Periodontal Research|November 1, 1995

Synthesis of proinflammatory cytokines by human gingival fibroblasts in response to lipopolysaccharides and interleukin-1 betaS Agarwal, C Baran, N P Piesco, et al.

Veterinary Immunology and Immunopathology|December 1, 1989

In vitro induction of swine peripheral blood monocyte proliferation by the fibroblast-derived murine hematopoietic growth factor CSF-1E V Genovesi, R C Knudsen, D J Gerstner, et al.

Revista De Neurologia|November 24, 1999

[Bourneville's tuberous sclerosis associated with double uterus and vagina (didelphic uterus)]C H Castaño-Duque, M Nadal, J C Quintero, et al.

Journal of Virology|September 1, 1991

Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitorsJ H Nunberg, W A Schleif, E J Boots, et al.

Nature|April 6, 1995

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsJ H Condra, W A Schleif, O M Blahy, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitorJ P Vacca, B D Dorsey, W A Schleif, et al.

Journal of Medicinal Chemistry|October 14, 1994

L-735,524: the design of a potent and orally bioavailable HIV protease inhibitorB D Dorsey, R B Levin, S L McDaniel, et al.

Drug Design and Discovery|January 1, 1993

HIV-1 protease inhibitors: synthesis and biological evaluation of glycopeptidemimeticsA K Ghosh, S P McKee, W M Sanders, et al.

Journal of Medicinal Chemistry|May 15, 1992

Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted designW J Thompson, P M Fitzgerald, M K Holloway, et al.

Pageof 3